EHP Funds’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
MBAM
EHP Funds's XGN Position: Q4 2025 in Review
EHP Funds sold out of Exagen (XGN) in Q4 2025, closing a stake of 90,807 shares — an estimated $998K sold.
EHP Funds first reported a position in XGN in Q3 2025 and held it in 1 quarter. The position peaked at $998K in Q3 2025. 80 funds tracked by Wall St. Rank hold XGN as of Q4 2025.
- EHP Funds reported no remaining Exagen position as of Q4 2025 after selling out during the quarter.
- EHP Funds sold 90,807 Exagen shares in Q4 2025, an estimated $998K.
- EHP Funds first reported a position in Exagen in Q3 2025 and held it in 1 quarter.
- EHP Funds's Exagen position peaked at $998K in Q3 2025.
- 80 funds tracked by Wall St. Rank held Exagen as of Q4 2025.
Based on EHP Funds's 13F filing for Q4 2025, filed 12 Feb 2026.